Many cancer patients will develop complex pain syndromes requiring aggressive, innovative, and comprehensive multimodal pain management strategies. Recently, data from both animal studies and clinical trials have allowed clinical research to focus on creating applicable clinical treatment strategies. This article is a review of genomic and molecular data, which has contributed to creating novel modalities for use in clinical pain management of patients with cancer-induced pain.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/jso.21707 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!